Cargando…
Prevalence of mutations in the cysteine desulfurase IscS (Pfnfs1) gene in recurrent Plasmodium falciparum infections following artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) treatment in Matayos, Western Kenya
BACKGROUND: Malaria remains a public health concern globally. Resistance to anti-malarial drugs has consistently threatened the gains in controlling the malaria parasites. Currently, artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP) are the treatment regimens against Plasmodium fa...
Autores principales: | Gachie, Beatrice, Thiong’o, Kelvin, Muriithi, Brenda, Chepngetich, Jean, Onchieku, Noah, Gathirwa, Jeremiah, Mwitari, Peter, Magoma, Gabriel, Kiboi, Daniel, Kimani, Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197370/ https://www.ncbi.nlm.nih.gov/pubmed/37202779 http://dx.doi.org/10.1186/s12936-023-04587-2 |
Ejemplares similares
-
Ferredoxin Competes with Bacterial Frataxin in Binding to the Desulfurase IscS
por: Yan, Robert, et al.
Publicado: (2013) -
Roles of conserved active site residues in the IscS cysteine desulfurase reaction
por: Pang, Yilin, et al.
Publicado: (2023) -
Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients
por: Wu, Wanting, et al.
Publicado: (2021) -
Deciphering the targets of retroviral protease inhibitors in Plasmodium berghei
por: Onchieku, Noah Machuki, et al.
Publicado: (2018) -
Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model
por: Gimode, Winnie R, et al.
Publicado: (2015)